Ditropan and Post procedural haemorrhage - a phase IV clinical study of FDA data

Summary:

Post procedural haemorrhage is reported as a side effect among people who take Ditropan (oxybutynin chloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Fosamax, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Post procedural haemorrhage when taking Ditropan. It is created by eHealthMe based on reports of 11,571 people who have side effects when taking Ditropan from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Post procedural haemorrhage?

Post procedural haemorrhage (post procedural bleeding) is found to be associated with 664 drugs and 854 conditions by eHealthMe. Check the latest studies of Post procedural haemorrhage.

On Jul, 13, 2026

11,571 people reported to have side effects when taking Ditropan.
Among them, 22 people (0.19%) have Post procedural haemorrhage.

Could Ditropan cause Post procedural haemorrhage?

Among these 22 people:

How long have people been on Ditropan when they have Post procedural haemorrhage? *

What is the gender of people who have Post procedural haemorrhage when taking Ditropan? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Post procedural haemorrhage when taking Ditropan? *

What are other drugs people take besides Ditropan? *

What are other side effects people have besides Post procedural haemorrhage? *

Stress And Anxiety: 15 people, 68.18%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 63.64%
Urinary Tract Infection: 13 people, 59.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 54.55%
Excoriation (to tear or wear off the skin of): 9 people, 40.91%
Cerebral Atrophy (decrement in size of brain): 9 people, 40.91%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 9 people, 40.91%
High Blood Cholesterol: 9 people, 40.91%
Depression: 9 people, 40.91%
Dislocation Of Vertebra: 9 people, 40.91%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 22.73%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.55%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 1 person, 4.55%
Migraine (headache): 1 person, 4.55%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%
Depression: 1 person, 4.55%
Bladder Disorder: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and have Post procedural haemorrhage?

- Check whether Post procedural haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ditropan:

Ditropan (11,799 reports)

Browse all side effects of Ditropan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural haemorrhage:

Post procedural haemorrhage (664 drugs)

Browse all the conditions that are associated with Post procedural haemorrhage:

Post procedural haemorrhage (854 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride (the active ingredients of Ditropan) and Ditropan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.